It should also be noted that although the presence of the high-risk genetic variants increases the susceptibility to several kidney diseases, most individuals with APOL1 high-risk variants will not develop kidney disease, harming the ability to predict the patient’s lifetime risk (Kopp and Winkler, 2020). The gene discussed is APOL1; the disease is kidney disorder.